Business Wire

Tech21 Announces New Collection Designed to Protect the Samsung Galaxy Note8 Drop After Drop.

Share

Tech21, the leader in impact protection for mobile devices, today announced a new collection of innovative cases and screen shields for the Samsung Galaxy Note8 made of unique, patented impact protection materials that guarantee the most effective drop protection on the market.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170823005888/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Evo Tactical for Samsung Galaxy Note8 (Photo: Business Wire)

Tech21 products are designed to protect, drop after drop. The company does this by using scientifically proven impact materials, innovative design and a rigorous testing methodology developed in partnership with the National Physical Laboratory. Tech21 cases are drop tested 20 times to ensure durability and long lasting protection able to withstand the multiple drops that occur in the everyday use of a smartphone.

The new range includes:

Cases to match all personalities

  • Evo Check – More Than Skin Deep. There’s more to Evo Check than meets the eye. This case adds a subtle detail to the Galaxy Note8’s original beauty. But sitting beneath its unique check pattern design is an effective three-layer protection system which includes FlexShock™, an impact material unique to tech21 that provides up to 3 metres/10 feet of drop protection. Evo Check comes in Smokey/Black and Clear/White. Available at tech21.com, Smokey/Black is also available at Three, EE, O2, Very.co.uk at MSRP £34.99 Clear/White is also available at Carphone Warehouse
  • Evo Tactical – Raw, Tactile Feel. Designed to endure the busy day ahead while complimenting the Galaxy Note8’s premium design, Evo Tactical combines durable materials with refined, contrasting textures. The case comes equipped with a three-layer protection system that includes FlexShock™, and offers drop protection up to 3 metres/10 feet. The Evo Tactical case comes in black. Available at tech21.com and Carphone Warehouse at MSRP £34.99
  • Evo Wallet – Access Everything. Comfortably. With busy lifestyles we want quick and easy access to the things we use most throughout the day – our phone and our cards. The Evo Wallet features two concealed card slots in its folio cover, where cards are kept secure and easily accessible. With FlexShock™, the case also provides up to 3 metres/10 feet of drop protection. The Evo Wallet case comes in black. Available at tech21.com, Carphone Warehouse, O2 and Very.co.uk at MSRP £44.99
  • Pure Clear – Protect. Reveal. The Galaxy Note8 is beautifully designed, and a case should enhance this design. Using new materials and cutting edge technology, Pure Clear is significantly more transparent than any other clear case. Featuring BulletShield™, it’s also 50% thinner and 50% lighter than the market leader and provides up to 2 metres/6.6 feet of drop protection. Available at tech21.com, Carphone Warehouse, O2 and Very.co.uk at MSRP £34.99

Market leading screen protection

  • Impact Shield with Anti-Scratch – Advanced protection. Enduring clarity. Designed to work perfectly with the subtle curves of your screen while the strong, lasting adhesive holds it in place from edge to edge, Impact Shield Anti-Scratch has a hard, durable coating which keeps your screen smooth and crystal clear for longer than ever. It also comes equipped with BulletShield™ to absorb impact force and eliminate the fear of damaging your screen. Available at tech21.com, Carphone Warehouse, O2 and Very.co.uk at MSRP £29.99

About tech21
Since 2005, tech21 has been developing the most advanced, scientifically proven cases and screen shields for mobile, tablet and laptop devices worldwide. tech21 combines science, engineering and British design to create products that address three core consumer benefits: style, protection and performance. As the brand evolves to continue meeting the needs of its consumers, tech21 has developed the most advanced impact protection material on the market – FlexShock™. The ultra-thin and lightweight material absorbs and dissipates force and can withstand drops up to 10 feet. In addition, tech21 puts all its products through a rigorous testing program, and in an industry first has partnered with the National Physical Laboratory (NPL) to develop its testing methodology. This ensures that the tests tech21 products have to pass are overseen by independent experts. Tech21 is the number one case brand in the UK. For more information, visit tech21.com.

//

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Atomic PR on behalf of tech21
Mark Dickens
Phone: (0)20 3861 3901
Email: Tech21@atomicpr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 03:09:00 EEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio ha

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye